153 results
Page 4 of 8
6-K
EX-99.1
l4zry9
12 Nov 20
BELLUS Health Reports Third Quarter 2020 Financial Results and Business Highlights
7:01am
SUPPL
lzi0imtyzga s84kz5d7
20 Oct 20
Supplemental materials (foreign)
12:00am
SUPPL
m1fl0
19 Oct 20
Supplemental materials (foreign)
5:12pm
6-K
EX-99.1
tw4khkx0x
8 Sep 20
BELLUS Health Announces Design for its Phase 2b Trial with BLU-5937 in Refractory Chronic Cough
7:00am
6-K
EX-99.2
b0khy jydk6
13 Aug 20
Condensed Consolidated Interim Financial Statements of
4:01pm
6-K
EX-99.1
lfjgkacrbjjj 73
6 Jul 20
BELLUS Health Announces Topline Results from its Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
EX-99.2
4jx3z8mj5wyupgvh
14 May 20
Condensed Consolidated Interim Financial Statements of
5:12pm
6-K
EX-99.2
xmdj2x4iduvl3
8 Apr 20
Notice of Annual and Special Meeting of Shareholders
9:41am
6-K
EX-99.1
p1g1 ixvf0ceydjod
7 Apr 20
Bellus HEALTH 2019 ANNUAL REPORT
9:59am
SUPPL
ilu1eti6os
23 Mar 20
Supplemental materials (foreign)
7:06am
40-F
EX-99.1
eqcq8e
27 Feb 20
Annual report (Canada)
5:13pm
40-F
EX-99.3
zu7vifrbo41a kksjrub
27 Feb 20
Annual report (Canada)
5:13pm
F-10/A
zl0f9
17 Jan 20
Registration of securities (Canada) (amended)
4:21pm
F-10
EX-4.1
xtldeztej5fmb1lv62w
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
EX-4.4
u2enhc0vcpcmlj
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
ssiwcizi
20 Dec 19
Registration of securities (Canada)
4:03pm
6-K
EX-99.1
o54 khw53b
14 Nov 19
BELLUS Health Reports Financial and Operating Results for the Third Quarter Ended
7:00am
SUPPL
4g2kz gqtk
5 Sep 19
Supplemental materials (foreign)
3:52pm
F-10
zz908s4rf 9n59qxo
3 Sep 19
Registration of securities (Canada)
7:53am
F-10
EX-4.4
0wf3yjqywgs2
3 Sep 19
Registration of securities (Canada)
7:53am